The Thoratec ventricular assist device (VAD) offers a final hope for survival in patients with severe cardiogenic shock unresponsive to conventional therapy. In select patients, these pneumatically activated prosthetic ventricles maintain organ perfusion pending recovery of the native heart or cardiac transplant. A detailed review of Thoratec VAD operation, its impact on the circulatory pathway and hemodynamic monitoring, and troubleshooting guidelines specific to these patients are presented. A nursing diagnosis framework assists with the identification and management of problems such as impaired cardiac output and gas exchange, as well as altered mobility, nutrition, and coping. Current information regarding the etiology and management of complications such as bleeding, infection, and end-organ failure are reviewed. A case study presentation offers guidelines for weaning patients from the VAD and includes a comprehensive nursing care plan for these challenging patients
Skip Nav Destination
Cirdiac Assist Devices| August 01 1991
The Thoratec Ventricular Assist Device: Nursing Guidelines
S. Jill Ley, RN, MS, CCRN
From the Pacific Presbyterian Medical Center, San Francisco, California.
Reprint requests to S. Jill Ley, RN, MS, CCRN, Pacific Presbyterian Medical Center, 2351 Clay St.— S31-I, San Francisco, CA 9-4 115.
Search for other works by this author on:
AACN Adv Crit Care (1991) 2 (3): 529–544.
S. Jill Ley; The Thoratec Ventricular Assist Device: Nursing Guidelines. AACN Adv Crit Care 1 August 1991; 2 (3): 529–544. doi: https://doi.org/10.4037/15597768-1991-3017
Download citation file:
Don't already have an account? Register
AACN AccountSign In
Sign in via your InstitutionSign in via your Institution
Subscribe online and gain access to the entire archive.
Purchase short-term access on a pay-per-article or pay-per-issue basis.
$15 72 - hour single article access $30 7 - day full issue access